Recall of Magnetic Floating Stackers Due to Risk of Serious Injury or Death
Tegu’s Magnetic Floating Stackers are children’s wooden toys that have a base, six pieces of different colors that stack, two posts, and two figures. All of these connect with magnets. Recently, Tegu recalled the Magnetic Floating Stackers toys due to the risk that a child would ingest the magnet, risk of serious injury or death, and a violation of the mandatory standard for toy magnets. If your child was harmed after ingesting magnets from the Teju magnetic floating stackers, you should call the seasoned Chicago-based product liability lawyers of Moll Law Group. Billions have been recovered in cases with which we’ve been involved.
Call Moll Law Group About Your Magnetic Floating Stackers Claim
The Tegu Magnetic Floating Stackers were recalled on July 31, 2025—the recall affects 25,850 units in the country. The reason that the toys violate the mandatory standard for this type of toy is because the high-powered magnets in them can get loose and break free from the toy, presenting a danger to children. The consumed magnets may attract each other within a child’s digestive system. The result may be twisting, blockage of the intestine, perforations, blood poisoning, and even death. So far, there have been 31 reports to Tegu of magnets detaching from the toy stacker.
The affected model numbers are STA-BGY-801T (Rainbow) and STA-BTP-806T (Big Top). These were sold for around $40 at toy, children’s stores, and specialty stores around the country, and also on Tegu.com and Amazon.com from August 2018-April 2025). Consumers have been asked to take the product from children and reach out to the manufacturer for instructions to receive a free replacement stacker toy. However, if your child was injured or killed due to ingesting magnets, you should keep any remaining pieces in case they’re needed as evidence.
Illinois Injury and Mass Tort Lawyer Blog


In May of this year, the manufacturer Medtronic voluntarily
Two brands of tomatoes from Williams Farms Repack, LLC were recalled in May in 14 states because of the risk of salmonella contamination. A little over a month ago, the recall was elevated to a
When there are a number of different cases pending in various districts against common defendants and featuring common factual and legal issues, it may be appropriate for plaintiffs to seek to have the cases centralized in a single district. When cases are centralized in this way, pretrial proceedings and discovery can be streamlined. Centralization also prevents judges’ inconsistent rulings on various pretrial matters, particularly evidentiary challenges.
The United States Department of Agriculture’s Food Safety and Inspection Service (FSIS)
Recently, on May 29, 2025, the
A
Seasonal allergies are triggered by pollen and blooming flowers and other plants. Allergy symptoms include runny noses, itchy eyes, sneezing, and sometimes coughing. Patients have been prescribed medications, and in some cases, take over-the-counter allergy medication.
On May 1, 2025, SharkNinja Foodi OP Series Multi-Function Pressure Cookers were
Two Alzheimer’s drugs Leqembi and Kisunla were approved by the FDA to treat mild dementia or a pre-Alzheimer’s condition called mild cognitive impairment. Data had suggested that Leqembi could slow cognitive decline in Alzheimer’s patients by five months over a period of 18 months for patients who had only mild symptoms. Two thousand volunteers had agreed to test Leqembi in clinical studies. However, it turns out these drugs may also increase the risk for brain bleeds and swelling in patients with certain genetic profiles—and patients may not have been given